Video Experimental Relacionado
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
El gen estructural de S. cerevisiae para la citina sintasa no es necesario para la síntesis de citina in vivo
Cell
|July 18, 1986
Resumen
Los investigadores identificaron el gen CHS1, crucial para la producción de la citina sintasa en Saccharomyces cerevisiae. Esta enzima es vital para la integridad de la pared celular, y su gen fue clonado y caracterizado.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Genética de la levadura Genética de la levadura
Sus antecedentes:
- La citina sintasa es un zimógeno ligado a la membrana plasmática en Saccharomyces cerevisiae.
- La citina sintasa activada sintetiza citina insoluble, similar a la que se encuentra en las cicatrices de los brotes.
Objetivo del estudio:
- Clonar y caracterizar el gen CHS1 que codifica la citina sintasa.
- Confirmar CHS1 como el gen estructural de la quitina sintasa utilizando levadura de fisión.
Principales métodos:
- Aislamiento de mutantes con deficiencia de citina sintasa (chs1).
- Clonado del gen CHS1.
- Expresión de una proteína de fusión CHS1-lacZ en S. pombe.
- Experimentos de alteración genética CHSI.
Principales resultados:
- El gen CHS1 tiene un marco de lectura abierto de 3400 bases, que codifica una proteína de 130 kd.
- La expresión de CHS1-lacZ en S. pombe confería actividad de la citina sintetasa, confirmando el papel de CHS1.
- Las alteraciones del gen CHSI resultaron en la pérdida de la actividad de la citina sintetasa in vitro, pero mantuvieron la viabilidad y los niveles normales de citina in vivo.
Conclusiones:
- CHS1 es el gen estructural para la citina sintasa en S. cerevisiae.
- La alteración de CHS1 afecta la actividad de la citina sintetasa, pero no la viabilidad celular o las funciones esenciales.
Videos de Conceptos Relacionados
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K